ABL.XETRA Abbott Laboratories

Healthcare Health Care Equipment & Supplies XETRA Stock Exchange
101.15 EUR
Close of Nov 5, 2026
69.17 110.54
Market cap
EUR 175B
P/E
43.4x
P/B
3.87x
ROE
7.6%
Dividend yield
2.20%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is ABL.XETRA undervalued?

Graham number
Price101.15
Graham value37.00
Premium173.4%

ABL.XETRA trades 173.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Abbott Laboratories fundamental analysis

No fundamental analysis for Abbott Laboratories yet.

Abbott Laboratories stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hor…

Full company profile